tau 284 has been researched along with alcaftadine in 3 studies
| Studies (tau 284) | Trials (tau 284) | Recent Studies (post-2010) (tau 284) | Studies (alcaftadine) | Trials (alcaftadine) | Recent Studies (post-2010) (alcaftadine) |
|---|---|---|---|---|---|
| 52 | 18 | 21 | 22 | 7 | 19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Babu, M; Dudeja, I; Dudeja, L; Janakiraman, A; Sane, K | 1 |
| Fordjuor, G; Kim, SI; Lee, JE; Lee, JH; Lee, JS; Park, CY | 1 |
| Ayyappanavar, S; Gangasagara, SB; Jayanthi, CR; Kumar, K; Mittal, P; Preethi, B; Rathod, BLS; Sridhar, S | 1 |
2 trial(s) available for tau 284 and alcaftadine
| Article | Year |
|---|---|
Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis.
Topics: Adolescent; Adult; Anti-Allergic Agents; Benzazepines; Child; Conjunctiva; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Imidazoles; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Piperidines; Prospective Studies; Pyridines; Single-Blind Method; Treatment Outcome; Young Adult | 2019 |
Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis.
Topics: Anti-Allergic Agents; Benzazepines; Conjunctivitis, Allergic; Double-Blind Method; Humans; Imidazoles; Olopatadine Hydrochloride; Ophthalmic Solutions; Piperidines; Prospective Studies; Pyridines; Treatment Outcome | 2021 |
1 other study(ies) available for tau 284 and alcaftadine
| Article | Year |
|---|---|
Comparison of cytotoxicities and anti-allergic effects of topical ocular dual-action anti-allergic agents.
Topics: Anti-Allergic Agents; Benzazepines; Cell Survival; Cells, Cultured; Conjunctiva; Cornea; Epithelial Cells; Humans; Imidazoles; Olopatadine Hydrochloride; Piperidines; Pyridines | 2019 |